BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23579984)

  • 41. Ectopic Salivary Gland in a Patient With Prostate Cancer at 18F-Choline PET/CT: An Incidental Finding.
    Cuppari L; Evangelista L
    Clin Nucl Med; 2018 Aug; 43(8):593-594. PubMed ID: 29847318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidental possible diagnosis by 18F-fluorocholine PET/CT of Meckel's diverticulum and potential pitfalls.
    Khor LK; Loi HY; Sinha AK; Lu SJ
    Hell J Nucl Med; 2015; 18(2):157-9. PubMed ID: 26187217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.
    Prichard RS; Cotter M; Evoy D; Gibbons D; Collins C; McDermott E; Skehan S
    Ir Med J; 2011 Jun; 104(6):177-9. PubMed ID: 22111394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
    Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
    World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
    J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
    Leboeuf R; Bénard F; Langlois MF
    Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain metastases in patient with prostate cancer found in 18F-choline PET/CT.
    Gizewska A; Witkowska-Patena E; Stembrowicz-Nowakowska Z; Buraczewska A; Dziuk M
    Nucl Med Rev Cent East Eur; 2015; 18(1):39-41. PubMed ID: 25633517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
    Vadrucci M; Gilardi L; Grana CM
    Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid incidentalomas on PET imaging--evaluation of management and clinical outcomes.
    Elzein S; Ahmed A; Lorenz E; Balasubramanian SP
    Surgeon; 2015 Apr; 13(2):116-20. PubMed ID: 25073933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
    Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
    BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.
    Chen YK; Ding HJ; Chen KT; Chen YL; Liao AC; Shen YY; Su CT; Kao CH
    Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.
    Rager O; Baskin A; Amzalag G; Buchegger F; Miralbell R; Ratib O; Zilli T; Garibotto V
    Nuklearmedizin; 2015; 54(5):211-6. PubMed ID: 26213186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
    García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value of thyroid incidentalomas on positron emission tomographic scans among thyroidectomy patients.
    Amir A; Karls S; Sands N; Forest VI; Hier M; Gologan O; Payne R
    J Otolaryngol Head Neck Surg; 2011 Oct; 40(5):391-5. PubMed ID: 22420394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Thymic uptake of 18FFDG following radioiodine ablation therapy].
    Albalá González MD; Martínez Gimeno E; Cárdenas Negro C; Allende Riera A; Cabello García D; De Sequera Rahola M; Uña Gorospe JA
    Rev Esp Med Nucl; 2011; 30(5):314-6. PubMed ID: 21342725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 18F-fluorocholine uptake in a case of adrenal incidentaloma: possible diagnostic pitfall or potential tool for adrenocortical tumors characterization?
    Imperiale A; Cabral JF; Rust E; Flores-Turk G; Renard C; Hubele F; Detour J; Lang H; Gangi A; Namer IJ
    Clin Nucl Med; 2013 Feb; 38(2):e83-4. PubMed ID: 23334144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Collision Intrathyroidal Tumor Causing Primary Hyperparathyroidism: Evidence From an 18F-Choline PET/CT Study.
    Foppiani L; Sola S; Pitto F; Ansaldo G; Piccardo A
    Clin Nucl Med; 2021 Nov; 46(11):924-926. PubMed ID: 33867452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: can PSA and PSA density help in patient selection?
    Calabria F; Chiaravalloti A; Tavolozza M; Ragano-Caracciolo C; Schillaci O
    Nucl Med Commun; 2013 Aug; 34(8):733-40. PubMed ID: 23680652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.